BAVARIAN NORDIC R/I S/ADR (BVNRY)
BVNRY moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How BVNRY actually reacts to news — the realized, point-in-time move the market made, measured across 190 labeled events over the last three years with zero look-ahead.
BVNRY’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 19% | 156 |
| 30-min | 0.00% | 29% | 166 |
| 60-min | 0.00% | 30% | 169 |
| to close | 0.00% | 47% | 184 |
| Middle 50% of BVNRY reactions | 0.00% to +0.09% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 190 |
Half of all BAVARIAN NORDIC R/I S/ADR news events land between +0.00% and +0.09% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when BVNRY moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to BVNRY's baseline. Nothing else.
Recent BVNRY events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Bavarian Nordic Upgrades Full-Year 2026 Financial Guidance After Strong Travel Health Performance | Press release | GlobeNewswire | +0.02% | -0.52% | |
| Bavarian Nordic Reports Strong First Half 2026 Results | Press release | GlobeNewswire | -0.00% | -0.78% | |
| Bavarian Nordic’s Chikungunya Vaccine Submitted for Regulatory Approval in Brazil | Press release | GlobeNewswire | +0.00% | -2.38% | |
| Bavarian Nordic Receives Health Canada Approval for Chikungunya Vaccine | Press release | GlobeNewswire | +0.00% | +0.00% | |
| Bavarian Nordic Secures Additional Government Contract for the Supply of Smallpox/Mpox Vaccine | Press release | GlobeNewswire | +0.00% | -0.16% | |
| Bavarian Nordic Announces Sale of Priority Review Voucher for USD 160 Million | Press release | GlobeNewswire | +0.00% | +0.24% | |
| Bavarian Nordic Receives Positive CHMP Opinion for Chikungunya Vaccine for Persons Aged 12 and Older | Press release | GlobeNewswire | -0.16% | -0.60% | |
| Canada's Only Single-Dose Cholera Vaccine Available Nationwide | Press release | GlobeNewswire | -0.10% | +0.90% | |
| Bavarian Nordic Submits Data to EMA to Extend Mpox/Smallpox Vaccine Approval to Adolescents | Press release | GlobeNewswire | +0.79% | +0.14% | |
| Bavarian Nordic Announces FDA Acceptance and Priority Review of the BLA for its Chikungunya Vaccine | Press release | GlobeNewswire | +1.74% | +5.33% | |
| Bavarian Nordic Receives USD 156.8 Million from the U.S. Government for Additional Smallpox/Mpox Vaccine Production | Press release | GlobeNewswire | -0.07% | +2.34% | |
| Bavarian Nordic Submits Marketing Authorization Application for its Chikungunya Vaccine Candidate to EMA | Press release | GlobeNewswire | +0.68% | +3.55% | |
| Bavarian Nordic Completes BLA Submission to U.S. FDA for its Chikungunya Vaccine Candidate | Press release | GlobeNewswire | +0.27% | +0.27% | |
| Bavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Smallpox and Mpox Vaccine | Press release | GlobeNewswire | — | +1.94% | |
| Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate | Press release | GlobeNewswire | +0.00% | +1.12% | |
| Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S. | Press release | GlobeNewswire | +0.00% | +0.97% | |
| Bavarian Nordic’s Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines Agency | Press release | GlobeNewswire | +0.00% | +0.38% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the BVNRY section they belong to.
Where else BVNRY is measured.
BVNRY earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| BeiGene, Ltd. - American Depositary Shares (BGNE) | 191 | +0.11% | 52% |
| CYTODYN INC (CYDY) | 191 | -0.07% | 45% |
| U S STEM CELL INC (USRM) | 190 | 0.00% | 37% |
| InnovAge Holding Corp. (INNV) | 189 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is BAVARIAN NORDIC R/I S/ADR's median reaction calculated?
Every labeled BVNRY news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 190 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 29% of BVNRY's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does BVNRY's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.